Global Organ Preservation Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Preservation Soultion;

Intracellular Solutions, Extracellular Solutions, Colloids and Others.

By Technique;

Static Cold Storage (SCS) Technique, Hypothermic Machine Perfusion, and Normothermic Machine Perfusion.

By Organ;

Kidney, Liver, Lung, Heart, and Others.

By End-User;

Hospitals and Clinics, Organ Banks, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn390188792 Published Date: March, 2025 Updated Date: May, 2025

Introduction

Global Organ Preservation Market (USD Million), 2021 - 2031

In the year 2024, the Global Organ Preservation Market was valued at USD 2,293.03 million. The size of this market is expected to increase to USD 3,568.02 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.5%.

The global organ preservation market is seeing remarkable growth, driven by cutting-edge advancements in transplantation technology and a rise in the number of transplant surgeries conducted worldwide. Organ preservation plays a vital role in maintaining the viability and functionality of donor organs during transportation and pre-transplant phases, which significantly enhances patient outcomes and reduces the risk of organ rejection. Among the most widely used preservation methods, cold storage dominates with around 65% of usage, followed by hypothermic machine perfusion at 20%, and the emerging normothermic machine perfusion technique, which accounts for approximately 10–15%. These preservation techniques offer specific advantages tailored to various organ types and medical requirements.

Factors Driving Market Growth

The main driver of this market expansion is the growing incidence of end-stage organ failure, largely attributed to aging populations and a rise in chronic lifestyle-related conditions like diabetes, hypertension, and obesity. Approximately 10% of people worldwide are affected by chronic kidney disease, a leading cause of organ transplant demand. Currently, donor organ availability meets only 10–15% of the global demand for transplants, resulting in a critical shortage. This gap is amplifying the need for advanced organ preservation technologies, which can extend organ viability by 30–50% over traditional methods. These innovations are helping to increase the pool of organs that are viable for transplantation.

Government Initiatives and Investments

In addition to medical advancements, government policies and initiatives are playing a key role in accelerating market growth. Programs designed to raise awareness about organ donation and streamline transplantation systems have led to notable improvements. For example, organ donation registration rates have increased by 25–30% in regions that have implemented comprehensive awareness campaigns. Partnerships between healthcare providers, transplant centers, and regulatory bodies are enhancing organ procurement systems, allocation processes, and overall transplant success rates. Furthermore, increased investments from major industry players are driving research and development, with expected annual increases in R&D spending of 18–22%. These efforts are contributing to the development of next-generation preservation technologies that will improve access to transplantation services and address critical unmet needs in the global healthcare system.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Preservation Soultion
    2. Market Snapshot, By Technique
    3. Market Snapshot, By Organ
    4. Market Snapshot, By End-User
    5. Market Snapshot, By Region
  4. Global Organ Preservation Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Aging population
        2. Organ shortage
        3. Technological advancements
        4. Increased transplant surgeries
        5. Rising prevalence of chronic diseases
      2. Restraints
        1. Limited organ preservation methods
        2. Regulatory challenges
        3. High cost of organ preservation
        4. Lack of awareness
        5. Ethical concerns
      3. Opportunities
        1. Emerging markets
        2. Development of novel preservation solutions
        3. Collaborations and partnerships
        4. Focus on personalized medicine
        5. Growing medical tourism industry
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Organ Preservation Market, By Preservation Soultion, 2021 - 2031 (USD Million)
      1. Intracellular Solutions
      2. Extracellular Solutions
      3. Colloids
      4. Others
    2. Global Organ Preservation Market, By Technique, 2021 - 2031 (USD Million)
      1. Static Cold Storage (SCS) Technique
      2. Hypothermic Machine Perfusion
      3. Normothermic Machine Perfusion
    3. Global Organ Preservation Market, By Organ, 2021 - 2031 (USD Million)
      1. Kidney
      2. Liver
      3. Lung
      4. Heart
      5. Others
    4. Global Organ Preservation Market Market, By End-User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Clinics
      3. Organ Banks
      4. Others
    5. Global Organ Preservation Market Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. XVIVO Perfusion AB
      2. Organ Recovery Systems, Inc
      3. Preservation Solutions, Inc
      4. TransMedics, Inc
      5. Waters Medical Systems LLC
      6. OrganOx Limited
      7. Bridge to Life Ltd
      8. OrganAssist BV
      9. Essential Pharmaceuticals LLC
      10. 21st Century Medicine Inc
  7. Analyst Views
  8. Future Outlook of the Market